PortViewPortView
Eledon Pharmaceuticals logo

Eledon Pharmaceuticals (ELDN) Stock Analysis

NASDAQHealthcareBiotechnology

$2.98-0.87%
1-year price historyRange $1.39 – $4.36
52-week range$2.98
$1.35$4.60

What Eledon Pharmaceuticals does

Eledon Pharmaceuticals, Inc. is a clinical-stage biopharmaceutical firm dedicated to creating innovative treatments for individuals battling autoimmune disorders, amyotrophic lateral sclerosis (ALS), and those undergoing organ or cell transplantation. Their flagship therapeutic candidate, AT-1501, is a humanized monoclonal antibody engineered to specifically target CD40 Ligand, a crucial protein found on the surface of immune system T cells. This compound is currently undergoing Phase 2a clinical studies for ALS treatment and Phase 2 trials for islet cell transplantation, aiming to address type 1 diabetes. Previously known as Novus Therapeutics, Inc., the company adopted its current name, Eledon Pharmaceuticals, Inc., in January 2021. Its corporate headquarters are located in Irvine, California.

Key metrics

Market cap
$230.32M
P/E (TTM)
-3.88
EPS (TTM)
$-0.77
Beta
0.96
Dividend yield
0.00%
Revenue / share
$0.00
50-day avg
$3.67
200-day avg
$2.91
52-week high
$4.60
52-week low
$1.35
CEO
David-Alexandre C. Gros

ETFs linked to ELDN

Broad-market and Healthcare sector ETFs an investor holding Eledon Pharmaceuticals is often also exposed to. Open an ETF page to see its actual top holdings.

PortView Portfolio Insights

PortView analyzes how ELDN fits your actual portfolio — position weight, portfolio concentration, unrealized gain/loss, contribution to return, sector exposure, indirect exposure through the ETFs you hold, and correlation with your other holdings. Connect a portfolio to see your personalized figures; PortView never shows another user's private holdings.

Analyze ELDN in PortView →

Similar companies

Frequently asked questions

What is the ticker symbol for Eledon Pharmaceuticals?
Eledon Pharmaceuticals trades under the ticker ELDN on NASDAQ.
Which exchange is ELDN listed on?
ELDN is listed on NASDAQ.
What sector does Eledon Pharmaceuticals operate in?
Eledon Pharmaceuticals is classified in the Healthcare sector (Biotechnology industry).
How can PortView help analyze ELDN in a portfolio?
PortView shows ELDN's weight in your portfolio, its contribution to return and risk, sector exposure, indirect exposure through ETFs you own, and correlation with your other holdings.

The information provided by PortView is for informational and educational purposes only and does not constitute investment advice. Market data may be delayed. Past performance does not guarantee future results.